Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction

No effective treatment is yet available to reduce infarct size and improve clinical outcomes after acute myocardial infarction by enhancing early reperfusion therapy using primary percutaneous coronary intervention. The study showed that Kyoto University Substance 121 (KUS121) reduced endoplasmic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ide, Yuya, Horie, Takahiro, Saito, Naritatsu, Watanabe, Shin, Otani, Chiharu, Miyasaka, Yui, Kuwabara, Yasuhide, Nishino, Tomohiro, Nakao, Tetsushi, Nishiga, Masataka, Nishi, Hitoo, Nakashima, Yasuhiro, Nakazeki, Fumiko, Koyama, Satoshi, Kimura, Masahiro, Tsuji, Shuhei, Rodriguez, Randolph Ruiz, Xu, Sijia, Yamasaki, Tomohiro, Watanabe, Toshimitsu, Yamamoto, Masamichi, Yanagita, Motoko, Kimura, Takeshi, Kakizuka, Akira, Ono, Koh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
PRECLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834964/
https://www.ncbi.nlm.nih.gov/pubmed/31709319
http://dx.doi.org/10.1016/j.jacbts.2019.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834964/
https://www.ncbi.nlm.nih.gov/pubmed/31709319
http://dx.doi.org/10.1016/j.jacbts.2019.06.001

Ejemplares similares